ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SGP vs BBNX // ENTERPRISE SCALE & MARKET CAP

SpyGlass Pharma Inc. (NASDAQ) VS. Beta Bionics Inc. (NASDAQ) • 15-METRIC TALLY: SGP 3 — BBNX 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: SGP
market-cap
$1.09B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGP VS. BBNX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SGP BBNX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 55.40% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -22.10% -12.90 BBNX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -3.08% -5.88% +2.80 SGP /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 53.90% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 12.82 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 4/9 -2.00 BBNX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 72.1 45.8 +26.30 SGP /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $1.09B $955.8M $131.6M SGP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SGP REV BBNX REV SGP GROSS % BBNX GROSS % SGP FCF BBNX FCF
FY 2025 $0 $100.3M — 55.4% -$33.5M -$56.2M
FY 2024 $0 $65.1M — 55.1% -$24.0M -$51.7M
FY 2023 — $12.0M — — — -$32.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGP // BETA —
BBNX // BETA —